Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Keiichi Masuya & Naoki Teno. (2010) Small molecules for bone diseases. Expert Opinion on Therapeutic Patents 20:4, pages 563-582.
Read now
Read now
Enrico M Messalli & Cono Scaffa. (2009) Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update. International Journal of Women's Health 1, pages 11-20.
Read now
Read now
Dieter Brömme & Fabien Lecaille. (2009) Cathepsin K inhibitors for osteoporosis and potential off-target effects. Expert Opinion on Investigational Drugs 18:5, pages 585-600.
Read now
Read now
Sengen Sun. (2008) Bone disease drug discovery: examining the interactions between osteoblast and osteoclast. Expert Opinion on Therapeutic Targets 12:2, pages 239-251.
Read now
Read now
Jos H. H. Thijssen. (2007) Long-term effects of progestins on bone quality and fractures. Gynecological Endocrinology 23:sup1, pages 45-52.
Read now
Read now
Articles from other publishers (20)
Henrique Hadad, Laís Kawamata de Jesus, Ana Flávia Piquera Santos, Henrique Rinaldi Matheus, Letícia Gabriella de Souza Rodrigues, Pier Paolo Poli, Elcio Marcantonio Junior, Fernando Pozzi Semeghini Guastaldi, Carlo Maiorana, Juliano Milanezi de Almeida, Roberta Okamoto & Francisley Ávila Souza. (2022) Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw. Scientific Reports 12:1.
Crossref
Crossref
Silvia Trichilo & Peter Pivonka. 2018. Multiscale Mechanobiology of Bone Remodeling and Adaptation. Multiscale Mechanobiology of Bone Remodeling and Adaptation
61
121
.
Hua Bai, Danqing Jing, Hua Jiang & Shinan Yin. (2013) Pharmacokinetics, Tissue Distribution and Excretion of Recombinant Human Parathyroid Hormone 1–84 in Animals. Cell Biochemistry and Biophysics 66:2, pages 379-387.
Crossref
Crossref
Pinar Yildirim, Çinar Çeken, Reza Hassanpour, Sadik Esmelioglu & Mehmet Resit Tolun. (2011) Mining MEDLINE for the Treatment of Osteoporosis. Journal of Medical Systems 36:4, pages 2339-2347.
Crossref
Crossref
Shayne Cox GadGregory T. Wurz & Michael W. DeGregorio. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Megan M. Weivoda & Raymond J. Hohl. (2011) The effects of direct inhibition of geranylgeranyl pyrophosphate synthase on osteoblast differentiation. Journal of Cellular Biochemistry 112:6, pages 1506-1513.
Crossref
Crossref
Gregory M Peterson, Mark Naunton, Lisette K Tichelaar & Luigi Gennari. (2011) Lasofoxifene: Selective Estrogen Receptor Modulator for the Prevention and Treatment of Postmenopausal Osteoporosis. Annals of Pharmacotherapy 45:4, pages 499-509.
Crossref
Crossref
Changkang Pan, Joseph J. Valente, Rosario LoBrutto, Jennifer S. Pickett & Michael Motto. (2010) Combined application of high resolution and tandem mass spectrometers to characterize methionine oxidation in a parathyroid hormone formulation. Journal of Pharmaceutical Sciences 99:3, pages 1169-1179.
Crossref
Crossref
Teun M. Post, Serge C.L.M. Cremers, Thomas Kerbusch & Meindert Danhof. (2010) Bone Physiology, Disease and Treatment. Clinical Pharmacokinetics 49:2, pages 89-118.
Crossref
Crossref
Yun-mei Yang, Wei-dong Huang, Qiang-min Xie, Zhe-rong Xu, Qi-jiang Zhao, Xi-mei Wu, Fen-fen Li & Xin-wei Dong. (2009) Simvastatin attenuates TNF-α-induced growth inhibition and apoptosis in murine osteoblastic MC3T3-E1 cells. Inflammation Research 59:2, pages 151-157.
Crossref
Crossref
Seema Parikh, Jerry Avorn & Daniel H. Solomon. (2009) Pharmacological Management of Osteoporosis in Nursing Home Populations: A Systematic Review. Journal of the American Geriatrics Society 57:2, pages 327-334.
Crossref
Crossref
Ae Ra Kim, Soo-Jeong Lim & Beom-Jin Lee. (2009) Metabolic inhibition and kinetics of raloxifene by pharmaceutical excipients in human liver microsomes. International Journal of Pharmaceutics 368:1-2, pages 37-44.
Crossref
Crossref
Moises Auron-Gomez & Franklin Michota. (2008) Medical Management of Hip Fracture. Clinics in Geriatric Medicine 24:4, pages 701-719.
Crossref
Crossref
Robyn K Fuchs, Roger J Phipps & David B Burr. (2008) Recovery of Trabecular and Cortical Bone Turnover After Discontinuation of Risedronate and Alendronate Therapy in Ovariectomized Rats. Journal of Bone and Mineral Research 23:10, pages 1689-1697.
Crossref
Crossref
O. Malaise, A. Neuprez & J.-Y. Reginster. (2008) Traitements non hormonaux de l’ostéoporose postménopausique. Gynécologie Obstétrique & Fertilité 36:7-8, pages 815-822.
Crossref
Crossref
Sylvie Desmarais, W. Cameron Black, Renata Oballa, Sonia Lamontagne, Denis Riendeau, Paul Tawa, Le Thi Duong, Maureen Pickarski & M. David Percival. (2008) Effect of Cathepsin K Inhibitor Basicity on in Vivo Off-Target Activities. Molecular Pharmacology 73:1, pages 147-156.
Crossref
Crossref
N. Yarom, R. Yahalom, Y. Shoshani, W. Hamed, E. Regev & S. Elad. (2007) Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome. Osteoporosis International 18:10, pages 1363-1370.
Crossref
Crossref
Sibel Özbudak Demir, Ceyda Akn, Meltem Aras & Füsun Köseoğlu. (2007) Spinal Cord Injury Associated with Thoracic Osteoporotic Fracture. American Journal of Physical Medicine & Rehabilitation 86:3, pages 242-246.
Crossref
Crossref
Demetra Kyriakides & Irene Panderi. (2007) Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations. Analytica Chimica Acta 584:1, pages 153-159.
Crossref
Crossref
Jean-Yves Reginster, Olivier Malaise, Audrey Neuprez, Victor-Emmanuel Jouret & Pierre Close. (2007) Intermittent Bisphosphonate Therapy in Postmenopausal Osteoporosis. Drugs & Aging 24:5, pages 351-359.
Crossref
Crossref